false 0000855683 0000855683 2024-09-27 2024-09-27
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): September 27, 2024
 
MILESTONE SCIENTIFIC INC.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware
 
001-14053
 
13-3545623
(State or Other Jurisdiction
of Incorporation)
 
(Commission File Number)
 
(I.R.S. Employer
Identification Number)
 
425 Eagle Rock Avenue
Suite 403
Roseland, NJ 07068
(Address of principal executive offices)
 
973-535-2717
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14d-2(b)
 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name on exchange on which registered
Common Stock
MLSS
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
 
Item 7.01 Regulation FD Disclosure.
 
On September 27, 2024, the Company published an investor presentation on its website at https://tffpharma.com/investors/. A copy of the investor presentation is attached as Exhibit 99.1 hereto.
 
The information in this Item 7.01, including the investor presentation attached as Exhibit 99.1, is furnished pursuant to Item 7.01 but shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall either be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
 
Item 9.01 Financial Statements and Exhibits
 
(d)
Exhibits
Method Filing
 
Exhibit 99.1
Filed Electronically herewith
     
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 
1

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MILESTONE SCIENTIFIC INC.
 
     
Dated: September 27, 2024
/s/ Arjan Haverhals
 
 
Arjan Haverhals,
 
 
Chief Executive Officer
 
 
2

Exhibit 99.1

 

 

 

slide01.jpg

 

 

 

 
slide02.jpg

 

 

 
slide03.jpg

 

 

 
slide04.jpg

 

 

 
slide05.jpg

 

 

 
slide06.jpg

 

 

 
slide07.jpg

 

 

 
slide08.jpg

 

 

 
slide09.jpg

 

 

 
slide10.jpg

 

 

 
slide11.jpg

 

 

 
slide12.jpg

 

 

 
slide13.jpg

 

 

 
slide14.jpg

 

 
v3.24.3
Document And Entity Information
Sep. 27, 2024
Document Information [Line Items]  
Entity, Registrant Name MILESTONE SCIENTIFIC INC.
Document, Type 8-K
Document, Period End Date Sep. 27, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-14053
Entity, Tax Identification Number 13-3545623
Entity, Address, Address Line One 425 Eagle Rock Avenue
Entity, Address, Address Line Two Suite 403
Entity, Address, City or Town Roseland
Entity, Address, State or Province NJ
Entity, Address, Postal Zip Code 07068
City Area Code 973
Local Phone Number 535-2717
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol MLSS
Security Exchange Name NYSE
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000855683

Grafico Azioni Milestone Scientific (AMEX:MLSS)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Milestone Scientific
Grafico Azioni Milestone Scientific (AMEX:MLSS)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Milestone Scientific